Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Cash & Equivalents (2020 - 2025)

Alignment Healthcare's Cash & Equivalents history spans 6 years, with the latest figure at $575.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 33.03% year-over-year to $575.8 million; the TTM value through Dec 2025 reached $575.8 million, up 33.03%, while the annual FY2025 figure was $575.8 million, 33.03% up from the prior year.
  • Cash & Equivalents reached $575.8 million in Q4 2025 per ALHC's latest filing, down from $618.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $618.1 million in Q3 2025 to a low of $3.4 million in Q3 2021.
  • Average Cash & Equivalents over 5 years is $404.2 million, with a median of $432.9 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: surged 16594.5% in 2022, then tumbled 50.46% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $466.6 million in 2021, then dropped by 12.23% to $409.5 million in 2022, then crashed by 50.46% to $202.9 million in 2023, then surged by 113.33% to $432.9 million in 2024, then skyrocketed by 33.03% to $575.8 million in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Cash & Equivalents are $575.8 million (Q4 2025), $618.1 million (Q3 2025), and $470.3 million (Q2 2025).